• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Hyperthyroidism Is Associated with Lower Quality of Life in Upper Egypt Study

by
November 17, 2026
in Health
Reading Time: 3 mins read
0
Hyperthyroidism Is Associated with Lower Quality of Life in Upper Egypt Study

Hyperthyroidism Is Associated with Lower Quality of Life in Upper Egypt Study

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Hyperthyroid patients experience significantly lower general and thyroid-specific quality of life compared with age- and sex-matched euthyroid controls, according to a case-control investigation conducted in Upper Egypt. The clinical study evaluated patient-reported health outcomes among individuals diagnosed with hyperthyroidism in Aswan Governorate, directly addressing an important gap in medical evidence from resource-limited healthcare settings where such data have historically remained scarce.

The impact of chronic diseases on patients' daily functioning represents a major public health matter. Although hyperthyroidism is recognized as a common endocrine disorder capable of substantially affecting quality of life, comprehensive evidence evaluating its full clinical and personal burden from resource-limited settings has continued to remain scarce in medical literature.

To address this knowledge gap, investigators conducted a comparative case-control study across two tertiary referral facilities located in Aswan Governorate. The research team enrolled a total of 155 hyperthyroid patients and compared them directly against 155 age- and sex-matched euthyroid control participants, establishing an organized clinical comparison to examine differences across sociodemographic and medical factors.

Data collection was carried out through structured face-to-face interviews using a semi-structured questionnaire covering participant sociodemographic characteristics alongside several established clinical evaluation tools. Investigators systematically administered the generic Short Form-36 Health Survey (SF-36), the disease-specific Thyroid-related Patient-Reported Outcome (ThyPRO) questionnaire, and the Thyroid Treatment Satisfaction Questionnaire (ThyTSQ). In addition to questionnaire responses, researchers performed standardized physical anthropometric measurements and diagnostic laboratory thyroid function tests for all participants.

The comparative results revealed that hyperthyroid patients had significantly lower SF-36 scores across all measured health domains compared with the matched control cohort (p < 0.001). Furthermore, hyperthyroid patients demonstrated significantly higher total ThyPRO scores and higher scores across most individual disease domains than controls (p < 0.001 for all areas except sexual limitation, which registered p = 0.008). In contrast, hypothyroid-symptom scores were significantly lower among patients (p < 0.001), while scores assessing impaired social life showed no statistically significant difference between the two cohorts (p = 0.081).

Regarding medical management, approximately three quarters of the hyperthyroid cases (74.8 percent) reported regular adherence to their prescribed medication routines. Mean current treatment satisfaction of 36.57 ± 7.3 (SD) was significantly higher than satisfaction at illness onset of 23.06 ± 1.9 (SD) (p < 0.001).

A multivariable regression analysis identified hyperthyroidism status, coexisting chronic disease, and rural residence as independent factors significantly associated with lower generic SF-36 scores and higher ThyPRO impairment scores (p < 0.05). Based on these collective findings, the authors concluded that hyperthyroidism was significantly associated with lower general and thyroid-specific quality of life, particularly among rural residents and patients with comorbidities, suggesting that routine assessment of quality of life may help guide more patient-centered hyperthyroidism care in similar settings.

Subject of Research: Quality of life impairments among hyperthyroid patients in Upper Egypt

Article Title: Generic and thyroid-specific quality of life among hyperthyroid patients in Aswan, Egypt: a case-control study

Article References: Abdelrheem, S. S., Alburaiki, T., Mohamed, S. A., Darwish, T. M., Abdelhameid, M. A., & Osman, D. M. (2026). Generic and thyroid-specific quality of life among hyperthyroid patients in Aswan, Egypt: a case-control study. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-026-02729-6

Image Credits: AI Generated

DOI: 10.1186/s12902-026-02729-6

Keywords: hyperthyroidism, quality of life, Aswan Governorate, Upper Egypt, case-control study, SF-36, ThyPRO, ThyTSQ, treatment satisfaction, medication adherence, endocrine disorders, euthyroid controls, chronic disease comorbidities, rural healthcare, thyroid function tests, patient-reported outcomes, multivariable regression

News Source: Ophelia Keating. (November 17, 2026). Hyperthyroidism Is Associated with Lower Quality of Life in Upper Egypt Study. Scienmag.

Tags: Aswan Governoratecase-control studychronic disease comorbiditiesendocrine disorderseuthyroid controlshyperthyroidismMedication Adherencemultivariable regressionPatient-reported outcomesQuality of Liferural healthcareSF-36ThyPROthyroid function testsThyTSQtreatment satisfactionUpper Egypt
Share12Tweet7Share2ShareShareShare1

Related Posts

Aprepitant Increases Tacrolimus Clearance for Three Weeks After Stem Cell Transplantation

Aprepitant Increases Tacrolimus Clearance for Three Weeks After Stem Cell Transplantation

November 17, 2026
Refractory Generalized Myasthenia Gravis Incurs Substantially Higher Economic Burden in China

Refractory Generalized Myasthenia Gravis Incurs Substantially Higher Economic Burden in China

November 17, 2026

Cerebral Autoregulation Index Fluctuates Widely During One-Lung Ventilation in Two Cases

November 17, 2026

Empagliflozin Reduces Functional Tricuspid Regurgitation Without Inducing Ventricular Remodeling

November 17, 2026

POPULAR NEWS

  • Microbial Biomarkers Reshape Early Detection and Treatment Across Gastrointestinal Cancers

    Microbial Biomarkers Reshape Early Detection and Treatment Across Gastrointestinal Cancers

    29 shares
    Share 12 Tweet 7
  • Lasso-Logistic and Stepwise Methods Accurately Combine Markers Across Alzheimer’s Stages

    29 shares
    Share 12 Tweet 7
  • Review Evaluates How Polyclonal IgG Repertoires Modulate Developing and Ageing Lymphocytes

    29 shares
    Share 12 Tweet 7
  • Periodontal Treatment Reduces Gingival Fluid Prolactin Levels in Obese Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Aprepitant Increases Tacrolimus Clearance for Three Weeks After Stem Cell Transplantation

Refractory Generalized Myasthenia Gravis Incurs Substantially Higher Economic Burden in China

Cerebral Autoregulation Index Fluctuates Widely During One-Lung Ventilation in Two Cases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.